Ropark 1 mg Sun Pharmaceuticals Industries

All about product
Specification
Reviews
0
Questions
0
Out Of Stock
Product Code: EU14525
Reviews: 0
18.00€
Specifications: (See all)
Active substance
Ropinirole
Also known as
Pramipexole dihydrochloride
Blood pressure
May cause orthostatic hypotension (drop in blood pressure when standing up)
Chemical name
(S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine monohydrochloride
Dosage (medical)
Initial dose is typically 0.125 mg three times a day, may be increased gradually based on patient response and tolerability
Description

Key features of Ropark 1 mg Sun Pharmaceuticals Industries and its advantages

Ropark 1 mg Sun Pharmaceuticals Industries is an innovative medication designed to address specific therapeutic needs in the management of certain neurological conditions. This product leverages advanced pharmacological research to develop a formulation that not only targets symptoms effectively but also enhances the overall quality of life for patients. As a leader in the pharmaceutical market, Sun Pharmaceutical Industries has positioned Ropark as a reliable option for healthcare professionals seeking to provide optimal care to their patients.

One of the key features of Ropark is its carefully measured dosage, which ensures that patients receive an effective amount of the active ingredient while minimizing the potential for side effects. The 1 mg formulation is particularly advantageous for patients who require precise dosing for optimal therapeutic outcomes. Moreover, Ropark is produced under stringent quality control measures, ensuring that every tablet meets high safety and efficacy standards established by regulatory authorities.

From the perspective of market relevance, Ropark fulfills a significant gap in treatment options available for its target conditions. Its comprehensive approach to managing symptoms, coupled with the commitment of Sun Pharmaceutical Industries to ongoing research and development, establishes Ropark as a preferred choice among healthcare providers. Thus, patients can trust that Ropark not only cares for their immediate medical needs but also contributes to long-term wellness.

Positive pharmacological properties

The pharmacological properties of Ropark 1 mg incorporate various aspects that contribute to its effectiveness in treating its targeted neurological conditions. The active ingredient works synergistically with the body's neurobiological pathways, allowing for enhanced symptom relief and improved patient outcomes. This medication is designed to be well-tolerated by most patients, showcasing its favorable pharmacokinetics and pharmacodynamics.

However, it is crucial for patients and healthcare professionals to be aware of certain contraindications associated with its use. The following groups are advised to avoid Ropark:

  1. Patients who are hypersensitive to the active ingredient or any of its constituents.
  2. Individuals with a history of severe mental disorders that can be aggravated by this medication.
  3. Pregnant women, as the effects on fetal development are not fully understood.
  4. Children and adolescents under the age of 18, due to insufficient data on safety and efficacy in these populations.
  5. Patients with specific medical conditions, such as severe hepatic impairment, where medication metabolism may be adversely affected.

Active substance of Ropark 1 mg Sun Pharmaceuticals Industries

The active substance present in Ropark 1 mg is at the forefront of modern therapeutic trends. This active ingredient has undergone extensive investigation and development to ascertain its efficacy and safety profile. Alongside innovations in formulation technology, researchers are continuously exploring how this substance interacts at the molecular level, thereby enhancing its therapeutic effects and minimizing side effects.

Recent advancements in pharmaceutical technology have allowed for more precise delivery methods, which significantly improves patient adherence to medication regimens. Ongoing studies aim to optimize how the active substance works within the body, focusing on its bioavailability and pharmacokinetics. This research is crucial, as understanding the precise action of the active ingredient enables healthcare providers to tailor treatments according to individual patient needs.

Who is not recommended to use this medication

Before beginning any new medication, including Ropark 1 mg, it is essential to evaluate the safety considerations associated with its use. Responsible prescribing involves a thorough assessment of each patient's unique medical history and current conditions. Certain limitations exist regarding the use of this medication, which healthcare providers must consider carefully.

Patients with a known hypersensitivity to components of the formulation should refrain from using Ropark. Additionally, those with specific pre-existing medical conditions may find that this medication could potentially exacerbate their situation, requiring a deeper analysis of the risks versus benefits. Individuals currently taking multiple medications should also consult their healthcare provider to avoid interactions that may compromise safety or efficacy.

Where to purchase Ropark 1 mg Sun Pharmaceuticals Industries in the USA

In the USA, Ropark 1 mg Sun Pharmaceuticals Industries occupies a reputable position within its therapeutic niche. It is widely available through various channels, including pharmacies and online healthcare platforms, ensuring that patients can access this essential medication with ease. Its established reputation among healthcare professionals lends credibility to its use, making it a trusted choice for those seeking effective treatment options.

Understanding where to purchase Ropark goes hand in hand with recognizing the medication’s overall value. Patients are encouraged to engage in discussions with their healthcare providers regarding the potential benefits and implications of using Ropark as part of their treatment plan. As an effective therapeutic agent, Ropark not only meets patients' immediate healthcare needs but also contributes to broader health outcomes, fostering a better quality of life for those it serves.

Specifications
Features
Active substance
Ropinirole
Also known as
Pramipexole dihydrochloride
Blood pressure
May cause orthostatic hypotension (drop in blood pressure when standing up)
Chemical name
(S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine monohydrochloride
Dosage (medical)
Initial dose is typically 0.125 mg three times a day, may be increased gradually based on patient response and tolerability
Dosage (sports)
Not applicable as it is not used for athletic enhancement
Effects
Improves motor control, reduces rigidity and tremors in Parkinson's patients
Formula
C10H17N3S В· HCl
Half-life
8-12 hours
Hepatotoxicity
Low risk
Lab Test
Not typically required for monitoring
Main action
Mimics dopamine in the brain, used to treat symptoms of Parkinson’s disease
Side effects
Nausea, dizziness, hallucinations, insomnia, constipation, impulse control disorders
Storage conditions
Store at room temperature, away from moisture and heat
Strength
1mg
Substance class
Dopamine agonist
Trade name
Mirapex, Mirapex ER
Use in sports
None, not recognized as a performance enhancing drug
Water Retention
Minimal to none
Manufacturer
Sun Pharma Laboratories Ltd.
Packing
10 tabs/blister
Reviews
0 / 5
average product rating
0
0
0
0
0

There are no reviews for this product, be the first to leave your review.

Answers & questions

No questions about this product, be the first and ask your question.

Ropark 1 mg Sun Pharmaceuticals Industries
18.00€